Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis
Abroad (travel likely)RecruitingPHASE2
Conditions
Demodex Blepharitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Glaukos Clinical Study Site, Newport Beach, California, United States
Study leads
Study Director, MD
Study Director
Glaukos Corporation